Description
Product details
Cresp 200 mcg PFS Injection is an erythropoiesis-stimulating medicine used for the management of anaemia associated with chronic kidney disease (CKD) and anaemia caused by cancer chemotherapy. It supports the formation of new red blood cells by stimulating bone marrow activity, helping maintain appropriate haemoglobin levels. Benefits Anaemia Associated with Chronic Kidney Disease Patients with advanced kidney disease may develop anaemia because their bodies are unable to maintain adequate red blood cell production. Cresp 200 mcg PFS Injection helps increase red blood cell formation and may improve symptoms such as weakness, fatigue and reduced energy. Chemotherapy-Related Anaemia Chemotherapy can interfere with normal red blood cell production and lead to low haemoglobin levels. Cresp 200 mcg may be prescribed for suitable patients to support red blood cell production and manage chemotherapy-induced anaemia. How to Use Cresp 200 mcg PFS Injection should be administered only according to a doctor's instructions. The dose and treatment frequency are determined according to the patient's haemoglobin level, medical condition and response to therapy. Do not self-administer unless specifically instructed and trained by a healthcare professional. Possible Side Effects Reported side effects may include: High blood pressure Skin rash Injection-site pain Breathlessness Cough Peripheral oedema Low blood pressure during certain procedures Convulsions Thromboembolic events (blood clots) Consult your doctor if any side effect persists, becomes severe or causes concern. Important Precautions Regular monitoring of haemoglobin levels and blood pressure may be required during treatment. Patients should inform their doctor about existing medical conditions and other medicines they are taking.
